Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103946905 | 10394690 | 5 | F | 2014 | 20160811 | 20140820 | 20160818 | PER | US-AMGEN INC.-USASP2014062353 | AMGEN | 54.00 | YR | A | F | Y | 0.00000 | 20160818 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103946905 | 10394690 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWK | 1045374 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 103946905 | 10394690 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWK | 1063527 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 103946905 | 10394690 | 3 | C | PROLIA | DENOSUMAB | 1 | UNK | 0 | UNKNOWN FORMULATION | ||||||||||
| 103946905 | 10394690 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | UNK | 0 | |||||||||||
| 103946905 | 10394690 | 5 | C | TOPIRAMATE. | TOPIRAMATE | 1 | UNK | 0 | |||||||||||
| 103946905 | 10394690 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 103946905 | 10394690 | 7 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | 0 | |||||||||||
| 103946905 | 10394690 | 8 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | UNK | 0 | |||||||||||
| 103946905 | 10394690 | 9 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | UNK | 0 | |||||||||||
| 103946905 | 10394690 | 10 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 103946905 | 10394690 | 11 | C | WARFARIN | WARFARIN | 1 | UNK | 0 | |||||||||||
| 103946905 | 10394690 | 12 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | UNK | 0 | |||||||||||
| 103946905 | 10394690 | 13 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103946905 | 10394690 | 1 | Rheumatoid arthritis |
| 103946905 | 10394690 | 7 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103946905 | 10394690 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103946905 | 10394690 | Contusion | |
| 103946905 | 10394690 | Erythema | |
| 103946905 | 10394690 | Fatigue | |
| 103946905 | 10394690 | Headache | |
| 103946905 | 10394690 | Influenza | |
| 103946905 | 10394690 | Injection site rash | |
| 103946905 | 10394690 | Local swelling | |
| 103946905 | 10394690 | Mobility decreased | |
| 103946905 | 10394690 | Rheumatoid arthritis | |
| 103946905 | 10394690 | Scratch | |
| 103946905 | 10394690 | Upper respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103946905 | 10394690 | 1 | 20140805 | 0 |